“…In the family of NOS, inducible NOS (iNOS) is specifically involved in pathologic aspects with the overproduction of NO and can be expressed in response to proinflammatory agents such as interleukin-1b, tumor necrosis factor-a, and LPS in various cell types including macrophages, endothelial cells, and smooth muscle cells. As a part of our studies to characterize the bioactive components of natural medicines, we have investigated various NO production inhibitors, i.e., higher unsaturated fatty acids, 39) polyacetylenes, [40][41][42] coumarins, 40,42,43) flavonoids, 41,44,45) stilbenes, 46,47) lignans, [48][49][50] sesquiterpenes, [51][52][53][54][55][56][57][58] diterpenes, 59,60) triterpenes, 19,[61][62][63] diarylheptanoids, [64][65][66] cyclic peptides, 63) alkaloids, 67,68) and phenylpropanoids. 50,69,70) As a continuation of these studies on bioactive constituents of natural medicines, the effects of the mono-and triterpene constituents (1-5, 7-13) from the gum-resin of B. carterii on NO production from LPS-activated macrophages were examined, and the results were summarized in Table 3 …”